Skip to content 
Search

Latest Stories

Samaritans to shut 100+ branches in UK and Ireland under major restructure

Final decision expected in September following consultation

Samaritans branch closures

Samaritans currently has 22,000 listening volunteers

Alamy

Highlights

  • Samaritans plans to close at least half of its 200 branches over the next 7–10 years
  • Volunteers to be moved into larger regional hubs and remote call handling to be piloted
  • Charity says model is unsustainable; changes aim to increase volunteer flexibility and service capacity
  • Some volunteers express concern over the loss of smaller branch camaraderie and safe spaces
  • Final decision expected in September following consultation

Mental health charity plans shift to larger hubs and remote volunteering

Samaritans has announced plans to close at least 100 of its 201 branches across the UK and Ireland in the next seven to ten years, as part of a major restructuring strategy aimed at improving service delivery and reducing infrastructure costs.

The charity, which operates a 24/7 mental health helpline, says it intends to move volunteers into larger regional centres and trial a remote volunteering model. The shift is intended to provide greater flexibility, increase the number of volunteers on shift at any time, and reduce spending on building maintenance.


Concerns raised over impact on volunteers

Samaritans currently has 22,000 listening volunteers who answer calls and messages from people experiencing mental health crises. The helpline receives a call every 10 seconds, and many branches also offer in-person support.

In a video shared with volunteers, Chief Executive Julie Bentley said the charity’s limited fundraising income was increasingly being used to maintain physical branches, instead of improving services.

“Over 200 branches, varying in size from 10 to 300 volunteers, is not sustainable and hinders us providing the best possible service to people who need us,” she said.
“We are engaging with our volunteers on proposed improvements that will mean we are able to answer more calls, have more volunteers on duty, and be there for more people in their darkest moments.”

The charity emphasised that it does not intend to reduce the level of service it offers. Instead, it hopes to expand its reach by making buildings and shifts more accessible and increasing volunteer numbers through flexible models.

Volunteer response: fears of “call centre-style” culture

Despite the stated goals, some long-standing volunteers have raised concerns that the changes could lead to a loss of the close-knit environment offered by smaller branches. There is particular unease about the possible shift to a “call centre-style” approach, which some feel could compromise the sense of community and safety among volunteers.

One volunteer commented:

“The current system has operated very successfully for 70 years. Now they’re thinking of dismantling it. Almost every volunteer I’ve spoken to has said if they introduce call centres, we’re out.”

Others voiced discomfort at the idea of taking sensitive calls from home, even with video support from fellow volunteers, citing the importance of having a safe, supportive physical environment.

Financial pressures and long-term planning

The proposed changes come amid financial challenges for the organisation. In its 2023–24 accounts, Samaritans reported declining income for the third consecutive year and rising operational costs.

The charity’s accounts show:

  • £7 million allocated to fixed assets, including branches
  • A property maintenance fund of £28,000
  • A branch support fund of £287,000
  • £24.6 million in charitable income

Volunteers have requested more transparency around projected cost savings from branch closures and how these funds will be reinvested.

Consultation ongoing ahead of decision

Samaritans has said that no final decisions will be made until after a consultation period concludes in September. If approved, the changes will be introduced gradually over a number of years.

The charity maintains that modernising the structure is essential for long-term sustainability and to meet the evolving needs of callers and volunteers alike.

More For You

Mounjaro side effects

Social media has recently drawn attention to the psychological challenges

iStock

The silent emotional side effect of Mounjaro jabs users are just beginning to talk about

Highlights

  • Mounjaro (tirzepatide) is a diabetes drug also prescribed for weight loss
  • Users report emotional side effects, including low motivation and feeling “stuck”
  • A TikTok post describing the “slow middle” of weight loss struck a chord with others
  • The injection can support weight loss of up to 20% over a year
  • Drug is now sold in UK supermarkets including Tesco and Morrisons


While Mounjaro has become increasingly popular for aiding weight loss, users have begun highlighting a less-discussed side effect — an emotional downturn midway through treatment.

The medication, also known by its generic name tirzepatide, is a weekly injection originally developed to manage type 2 diabetes. It has since gained traction for its weight loss benefits, with some patients shedding up to 20% of their body weight over the course of a year.

Keep ReadingShow less
HPV vaccine 16 to 25

Many of those targeted missed their vaccine during school years

iStock

NHS steps up HPV vaccine rollout for young people aged 16–25

Highlights

  • NHS encourages unvaccinated people aged 16–25 to get the HPV vaccine
  • Over 418,000 school leavers in past three years missed vaccination
  • HPV vaccine protects against cervical and other related cancers
  • NHS aiming for 90% uptake among girls by 2040
  • Letters, emails, texts and NHS App alerts being used for reminders

NHS campaign targets unvaccinated young adults

The NHS is urging hundreds of thousands of young people aged 16 to 25 to come forward for the HPV vaccine, which protects against cervical and other types of cancer.

Many of those targeted missed their vaccine during school years. According to NHS England, over 418,000 children left school without receiving the HPV jab in the past three years.

Keep ReadingShow less
Bryan Johnson

He now believes that commercial interests may be at odds with his philosophical mission

Getty Images

Bryan Johnson may shut down anti-ageing startup to focus on religion

Highlights

  • Bryan Johnson, 47, is contemplating shutting down or selling his anti-ageing startup, Blueprint.
  • The biotech entrepreneur recently launched a religion called "Don’t Die."
  • He says commercial activity is undermining his philosophical credibility.
  • Blueprint has faced financial pressures but Johnson denies any crisis.

Biotech entrepreneur and longevity enthusiast Bryan Johnson has revealed he is considering shutting down or selling his anti-ageing company, Blueprint. Speaking to Wired, the 47-year-old said his priorities have shifted towards developing his newly founded religion, "Don’t Die", which he believes better aligns with his philosophical ambitions.

“I am so close to either shutting it down or selling it,” Johnson said in the interview published Monday. “I don’t need the money, and it’s a pain-in-the-ass company.”

Keep ReadingShow less
slimming jab Morrisons

The move has sparked criticism on social media

iStock

Morrisons launches £129-a-month weight loss injection service

Highlights

  • Morrisons Clinic introduces subscription service for tirzepatide injections
  • The treatment may aid weight loss of up to 20% over one year
  • Monthly subscription will increase from £129 to £159 after introductory period
  • Service includes medical assessment and regular check-ins
  • Criticism emerges over the supermarket’s continued sale of unhealthy food


Morrisons has launched an online subscription service offering weight loss injections, prompting mixed reactions from the public. The supermarket’s online health platform, Morrisons Clinic, now offers tirzepatide — also known by the brand name Mounjaro — for weight management.

Tirzepatide is primarily prescribed to treat type 2 diabetes, but has also been approved for weight loss. According to Morrisons Clinic, users may lose up to 20 per cent of their body weight over the course of a year.

Keep ReadingShow less
RSV vaccine premature babies

NHS England says premature babies are three times more likely to be hospitalised due to RSV

iStock

NHS to immunise premature babies against deadly winter virus RSV

Highlights

  • NHS to offer nirsevimab injection to 9,000 premature and high-risk babies from late September
  • Aims to protect against respiratory syncytial virus (RSV), which can cause severe illness in infants
  • Premature babies are 10 times more likely to need intensive care for RSV
  • Nirsevimab offers immediate protection and lasts for six months
  • Neo-natal units across the UK will deliver the jab

Thousands of premature and high-risk babies in the UK will soon be offered a new immunisation to protect against RSV (respiratory syncytial virus), a common winter virus that can cause serious lung infections and hospitalisation. The NHS will begin delivering the nirsevimab injection from late September, aiming to shield vulnerable infants before the colder months set in.

Premature infants at higher risk from RSV

RSV typically causes coughs and colds, but in some children — particularly those born prematurely or with underlying health conditions — it can lead to bronchiolitis, pneumonia, and breathing difficulties. NHS England says premature babies are three times more likely to be hospitalised due to RSV and ten times more likely to require intensive care compared to full-term infants.

Keep ReadingShow less